Follow
Giovanni Smania
Giovanni Smania
Pharmetheus
Verified email at pharmetheus.com
Title
Cited by
Cited by
Year
Conditional distribution modeling as an alternative method for covariates simulation: comparison with joint multivariate normal and bootstrap techniques
G Smania, EN Jonsson
CPT: pharmacometrics & systems pharmacology 10 (4), 330-339, 2021
132021
Translating QT interval prolongation from conscious dogs to humans
VFS Dubois, G Smania, H Yu, R Graf, ASY Chain, M Danhof, ...
British Journal of Clinical Pharmacology 83 (2), 349-362, 2017
132017
Model‐based assessment of alternative study designs in pediatric trials. Part II: Bayesian approaches
G Smania, P Baiardi, A Ceci, M Cella, P Magni
CPT: pharmacometrics & systems pharmacology 5 (8), 402-410, 2016
122016
Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
A Bauer, S Friberg-Hietala, G Smania, M Wolfsegger
Journal of Blood Medicine, 399-411, 2023
12023
Pharmacokinetic analysis of levodopa and carbidopa following subcutaneous infusion: A population pharmacokinetics model (2019)
T Birnberg, G Smania, M Bjornsson, N Jonsson, R Case, S Oren, L Adar, ...
Neurology 96 (15 Supplement), 2021
12021
Translational model-based approach to assist the dose-range selection of an antibody-drug conjugate entering Phase I
P Mazzei, G Smania, C Piana, P Magni, M Binaschi, M Bigioni, G Merlino, ...
PAGE Meeting, 2017
12017
Model-based comparison of alternative study designs in pediatric trials
G Smania, P Baiardi, M Cella, P Magni
Part II: Bayesian approaches. CPT Pharmacometrics Syst. Pharmacol.(submitted), 2015
12015
Population pharmacokinetics of levodopa and carbidopa following subcutaneous infusion
T Birnberg, L Adar, G Smania, M Bjornsson, N Jonsson, R Case, ...
Parkinsonism & Related Disorders 113, 2023
2023
Pharmacokinetic analysis of levodopa and carbidopa following subcutaneous infusion: A population pharmacokinetics model
T Birnberg, G Smania, M Bjornsson, N Jonsson, R Case, S Oren, L Adar, ...
EUROPEAN JOURNAL OF NEUROLOGY 28, 235-235, 2021
2021
Assessment of rVWF Pharmacokinetics in Overweight and Obese VWD Patients Using a Population Pharmacokinetic Model
SA Hale, A Bauer, G Smania, S Friberg-Hietala, MJ Wolfsegger
Blood 136, 7-8, 2020
2020
Population pharmacokinetic analysis of levodopa and carbidopa after subcutaneous administration with and without adjunct oral therapy
T Birnberg, G Smania, M Bjornsson, N Jonsson, R Case, S Oren, L Adar, ...
MOVEMENT DISORDERS 35, S389-S389, 2020
2020
Il modeling matematico, l'estrapolazione ei disegni di studio alternativi come strumenti per agevolare lo sviluppo pediatrico dei farmaci
G Smania
UniversitÓ degli studi di Pavia, 2017
2017
The role of modelling and simulation in the paediatric investigation plan of a xanthine oxidase inhibitor for tumor lysis syndrome prevention
G Smania, P Mazzei, C Piana, S Baldini, C Simonelli, A Capriati, ...
PAGE Meeting, 2017
2017
A model-based approach to extrapolate drug-drug interactions from rats to humans
C Piana, P Mazzei, G Smania, P Magni, A Lecci, A Capriati, A Pellacani
PAGE Meeting, 2017
2017
GRIP List of principles to be considered when evaluating extrapolation approach from adult data
G Smania, C Olivier, C Barker, P Baiardi, A Ceci, A Saint-Raymond, ...
HEALTH, 261060, 2015
2015
Clinical trial simulations as a tool to investigate innovative study designs in paediatric trials
G Smania, M Cella, P Baiardi, P Magni
Congresso nazionale di Bioingegneria 2014-Atti, M-51/1-3, 2014
2014
Conditional distribution modeling for covariates simulation using classification and regression trees methods
G Smania, EN Jonsson
Investigating the identifiability of one-stage IVIVC population models for extended-release dosage forms
S Zannoni, A Brekkan, G Smania
The system can't perform the operation now. Try again later.
Articles 1–18